Wirsching P - Search Results

1

Suppression of psychoactive effects of cocaine by active immunization.

Carrera MR, Ashley JA, Parsons LH, Wirsching P, Koob GF, Janda KD. Carrera MR, et al. Among authors: wirsching p. Nature. 1995 Dec 14;378(6558):727-30. doi: 10.1038/378727a0. Nature. 1995. PMID: 7501020

2

Investigations using immunization to attenuate the psychoactive effects of nicotine.

Carrera MR, Ashley JA, Hoffman TZ, Isomura S, Wirsching P, Koob GF, Janda KD. Carrera MR, et al. Among authors: wirsching p. Bioorg Med Chem. 2004 Feb 1;12(3):563-70. doi: 10.1016/j.bmc.2003.11.029. Bioorg Med Chem. 2004. PMID: 14738965

3

Cocaine vaccines: antibody protection against relapse in a rat model.

Carrera MR, Ashley JA, Zhou B, Wirsching P, Koob GF, Janda KD. Carrera MR, et al. Among authors: wirsching p. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6202-6. doi: 10.1073/pnas.97.11.6202. Proc Natl Acad Sci U S A. 2000. PMID: 10823960 Free PMC article.

4

A second-generation vaccine protects against the psychoactive effects of cocaine.

Carrera MR, Ashley JA, Wirsching P, Koob GF, Janda KD. Carrera MR, et al. Among authors: wirsching p. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1988-92. doi: 10.1073/pnas.98.4.1988. Epub 2001 Feb 6. Proc Natl Acad Sci U S A. 2001. PMID: 11172063 Free PMC article.

5

Cocaine catalytic antibodies: the primary importance of linker effects.

Matsushita M, Hoffman TZ, Ashley JA, Zhou B, Wirsching P, Janda KD. Matsushita M, et al. Among authors: wirsching p. Bioorg Med Chem Lett. 2001 Jan 22;11(2):87-90. doi: 10.1016/s0960-894x(00)00659-4. Bioorg Med Chem Lett. 2001. PMID: 11206477

6

Synthesis, properties, and reactivity of cocaine benzoylthio ester possessing the cocaine absolute configuration.

Isomura S, Hoffman TZ, Wirsching P, Janda KD. Isomura S, et al. Among authors: wirsching p. J Am Chem Soc. 2002 Apr 10;124(14):3661-8. doi: 10.1021/ja012376y. J Am Chem Soc. 2002. PMID: 11929256

7

Antibody-catalyzed cleavage of the D-Ala-D-Lac depsipeptide: an immunological approach to the problem of vancomycin resistance.

Isomura S, Ashley JA, Wirsching P, Janda KD. Isomura S, et al. Among authors: wirsching p. Bioorg Med Chem Lett. 2002 Mar 25;12(6):861-4. doi: 10.1016/s0960-894x(02)00047-1. Bioorg Med Chem Lett. 2002. PMID: 11958980

8

Expression and characterization of a humanized cocaine-binding antibody.

Redwan el-RM, Larsen NA, Zhou B, Wirsching P, Janda KD, Wilson IA. Redwan el-RM, et al. Among authors: wirsching p. Biotechnol Bioeng. 2003 Jun 5;82(5):612-8. doi: 10.1002/bit.10598. Biotechnol Bioeng. 2003. PMID: 12652485

9

A new strategy for improved nicotine vaccines using conformationally constrained haptens.

Meijler MM, Matsushita M, Altobell LJ 3rd, Wirsching P, Janda KD. Meijler MM, et al. Among authors: wirsching p. J Am Chem Soc. 2003 Jun 18;125(24):7164-5. doi: 10.1021/ja034805t. J Am Chem Soc. 2003. PMID: 12797775

10

Fluorescent cocaine probes: a tool for the selection and engineering of therapeutic antibodies.

Meijler MM, Kaufmann GF, Qi L, Mee JM, Coyle AR, Moss JA, Wirsching P, Matsushita M, Janda KD. Meijler MM, et al. Among authors: wirsching p. J Am Chem Soc. 2005 Mar 2;127(8):2477-84. doi: 10.1021/ja043935e. J Am Chem Soc. 2005. PMID: 15725002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters